Therapeutic Asset Ratings
1,179 results matching 1 filter
91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Vedolizumab
Melanoma
M.D. Anderson Cancer Center
P1/2
CC
(44)
Copanlisib
Ovarian Cancer
M.D. Anderson Cancer Center
P2
CC
(43)
Etigilimab
Ovarian Cancer
M.D. Anderson Cancer Center
P2
CC
(43)
Acetazolamide
Neoplasm
M.D. Anderson Cancer Center
P1
CC
(43)
ACETIC
Adult Hepatocellular Carcinoma
M.D. Anderson Cancer Center
P1
CC
(43)
ACETIC
Hepatobiliary Benign Neoplasm
M.D. Anderson Cancer Center
P1
CC
(43)
Adagrasib
Digestive System Cancer
M.D. Anderson Cancer Center
P1
CC
(43)
Alpelisib
Metastatic Malignant Neoplasm In The Brain
M.D. Anderson Cancer Center
P1
CC
(43)
Anti-Pr1/Hla-A2 Monoclonal Antibody Hu8F4
Acute Myeloid Leukemia
M.D. Anderson Cancer Center
P1
CC
(43)
Anti-Pr1/Hla-A2 Monoclonal Antibody Hu8F4
Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
M.D. Anderson Cancer Center
P1
CC
(43)
Anti-Pr1/Hla-A2 Monoclonal Antibody Hu8F4
Hematopoietic And Lymphoid Cell Neoplasm
M.D. Anderson Cancer Center
P1
CC
(43)
Anti-Pr1/Hla-A2 Monoclonal Antibody Hu8F4
Myelodysplastic Syndrome
M.D. Anderson Cancer Center
P1
CC
(43)
Anti-Pr1/Hla-A2 Monoclonal Antibody Hu8F4
Myelodysplastic Syndrome With Excess Blasts-1
M.D. Anderson Cancer Center
P1
CC
(43)
Anti-Pr1/Hla-A2 Monoclonal Antibody Hu8F4
Myelodysplastic Syndrome With Excess Blasts-2
M.D. Anderson Cancer Center
P1
CC
(43)
Anti-Pr1/Hla-A2 Monoclonal Antibody Hu8F4
Chronic Myelomonocytic Leukemia
M.D. Anderson Cancer Center
P1
CC
(43)
Atezolizumab
Uterine Corpus Cancer
M.D. Anderson Cancer Center
P1
CC
(43)
Cabozantinib
Endometrial Carcinoma
M.D. Anderson Cancer Center
P1
CC
(43)
Cabozantinib
Thoracic Cancer
M.D. Anderson Cancer Center
P1
CC
(43)
Cabozantinib
Fallopian Tube Cancer
M.D. Anderson Cancer Center
P1
CC
(43)
Cabozantinib
Ovarian Cancer
M.D. Anderson Cancer Center
P1
CC
(43)
Capivasertib
Head And Neck Squamous Cell Carcinoma
M.D. Anderson Cancer Center
P1
CC
(43)
Capivasertib
Ovarian Clear Cell Adenocarcinoma
M.D. Anderson Cancer Center
P1
CC
(43)
Capivasertib
Hereditary Breast Ovarian Cancer Syndrome
M.D. Anderson Cancer Center
P1
CC
(43)
Capivasertib
BRCA2-Related Cancer Predisposition
M.D. Anderson Cancer Center
P1
CC
(43)
Capivasertib
Chondrosarcoma
M.D. Anderson Cancer Center
P1
CC
(43)
Showing 826 to 850 of 1,179 assets
Previous
Page 34 of 48
Next